| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.62 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.14 | 0.2 |